MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, INDV made $317M in revenue. $89M in net income. Net profit margin of 28.08%.

Income Overview

Revenue
$317M
Net Income
$89M
Net Profit Margin
28.08%
EPS
$0.69
Unit: Million (M) dollars
Revenue Breakdown
    • Sublocade
    • Sublingual And Other
    • Non Us
    • Perseris

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net revenue
317 357 314 302
Cost of sales
40 67 83 52
Gross profit
277 293 230 250
Selling, general and administrative
124 189 155 158
Research and development
16 21 33 21
Acquired in-process research and development
-0* 0 -
Litigation settlement
--2 0 0
Other operating (income) expense, net
-0* -1 -
Total operating expenses
139 -187 -
Operating income
137 81 43 72
Interest (income)
3 6 6 6
Interest expense
7 6 12 15
Loss on debt extinguishment
-18 ---
Income before income taxes
115 81 37 62
Income tax expense
26 -21 -5 44
Net income
89 103 42 18
Foreign currency translation
---2
Other comprehensive income (loss)
---2
Total comprehensive income (loss)
---20
Basic EPS
0.71 0.786 0.34 0.15
Diluted EPS
0.69 0.75 0.33 0.14
Basic Average Shares
124,000,000 126,000,000 125,000,000 125,000,000
Diluted Average Shares
129,000,000 132,000,000 129,000,000 126,000,000
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Sublocade$218M (33.74%↑ Y/Y)Sublingual And Other$50M (-7.41%↓ Y/Y)Perseris$5M (25.00%↑ Y/Y)US$272M (22.52%↑ Y/Y)Non Us$45M (2.27%↑ Y/Y)Net revenue$317M (19.17%↑ Y/Y)Gross profit$277M (25.34%↑ Y/Y)Cost of sales$40M (-9.09%↓ Y/Y)Operating income$137M (107.58%↑ Y/Y)Interest (income)$3M (-25.00%↓ Y/Y)Total operatingexpenses$139M (-10.90%↓ Y/Y)Income before incometaxes$115M (94.92%↑ Y/Y)Loss on debtextinguishment-$18M Interest expense$7M (-41.67%↓ Y/Y)Selling, general andadministrative$124M (-6.06%↓ Y/Y)Research and development$16M (-27.27%↓ Y/Y)Net income$89M (89.36%↑ Y/Y)Income tax expense$26M (136.36%↑ Y/Y)

indivior-logo-svg

Indivior Pharmaceuticals, Inc. (INDV)

indivior-logo-svg

Indivior Pharmaceuticals, Inc. (INDV)